Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Atyr Pharma Inc (NASDAQ: ATYR) closed the day trading at $3.71 down -1.59% from the previous closing price of $3.77. In other words, the price has decreased by -$1.59 from its previous closing price. On the day, 0.51 million shares were traded. ATYR stock price reached its highest trading level at $3.75 during the session, while it also had its lowest trading level at $3.6.
Ratios:
For a better understanding of ATYR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.
On October 04, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $17.
On September 05, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $9.Jefferies initiated its Buy rating on September 05, 2024, with a $9 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 04 ’25 when Broadfoot Jill Marie sold 1,254 shares for $3.78 per share. The transaction valued at 4,740 led to the insider holds 31,763 shares of the business.
DENYES NANCY sold 899 shares of ATYR for $3,398 on Feb 04 ’25. The General Counsel now owns 26,555 shares after completing the transaction at $3.78 per share. On Jul 24 ’24, another insider, SCHIMMEL PAUL, who serves as the Director of the company, bought 52,300 shares for $1.93 each. As a result, the insider paid 101,038 and bolstered with 413,023 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATYR now has a Market Capitalization of 311426304 and an Enterprise Value of 258823328. For the stock, the TTM Price-to-Sale (P/S) ratio is 1354.02 while its Price-to-Book (P/B) ratio in mrq is 4.31. Its current Enterprise Value per Revenue stands at 1101.376 whereas that against EBITDA is -3.843.
Stock Price History:
The Beta on a monthly basis for ATYR is 1.00, which has changed by 0.9635416 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, ATYR has reached a high of $4.22, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 5.09%, while the 200-Day Moving Average is calculated to be 52.02%.
Shares Statistics:
Over the past 3-months, ATYR traded about 835.37K shares per day on average, while over the past 10 days, ATYR traded about 707070 shares per day. A total of 83.94M shares are outstanding, with a floating share count of 81.93M. Insiders hold about 2.40% of the company’s shares, while institutions hold 63.64% stake in the company. Shares short for ATYR as of 1738281600 were 3816730 with a Short Ratio of 4.21, compared to 1735603200 on 3647026. Therefore, it implies a Short% of Shares Outstanding of 3816730 and a Short% of Float of 5.9799999999999995.
